| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |